Effect of vasodilator therapy on mortality in chronic congestive heart failure - The New England Journal of Medicine - 1986
Brief Summary:
In the era before beta-blockers and ACE inhibitors, ISDN/hydralazine showed a trend towards improved survival among patients with systolic heart failure.Reference: http://www.ncbi.nlm.nih.gov/pubmed/3520315
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you